The Trypsin Market is Predict to reach USD 130.1 Million by 2031, at a CAGR of 5.2%

Trypsin Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Trypsin Market size is expected to reach $130.1 million by 2031, rising at a market growth of 5.2% CAGR during the forecast period.

The Porcine segment is anticipating a CAGR of 5.6% during (2024 - 2031). Porcine trypsin shares many similarities with bovine trypsin regarding enzymatic activity, stability, and performance characteristics. This similarity makes porcine trypsin a suitable replacement for bovine trypsin in various applications, including cell culture, protein digestion, and biochemical assays. Users familiar with bovine trypsin may easily transition to porcine trypsin without significant protocol or workflow changes.

The Biotechnology & Pharmaceutical Industry segment is leading the Global Trypsin Market by Application in 2023; thereby, achieving a market value of $62.1 million by 2031. Trypsin is widely used in cell culture applications for the detachment and subculture of adherent cells. In biopharmaceutical manufacturing, where cells are grown in culture to produce therapeutic proteins, vaccines, and monoclonal antibodies, trypsin is essential for cell harvesting and passaging. The scalability of cell culture processes in bioreactors necessitates large quantities of trypsin, driving significant demand from the biotechnology and pharmaceutical sectors.

The Research segment is registering a CAGR of 6.1% during (2024 - 2031). Proteomics is the large-scale study of proteins and their functions within a biological system. Trypsin plays a central role in proteomics research as it enables the analysis of complex protein mixtures by digesting proteins into peptides. Peptide mapping using trypsin digestion allows researchers to identify proteins, determine their amino acid sequences, and map post-translational modifications such as phosphorylation, glycosylation, and acetylation.

Full Report: https://www.kbvresearch.com/trypsin-market/

The North America region dominated the Global Trypsin Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $49.2 million by 2031. The Europe region is experiencing a CAGR of 4.9% during (2024 - 2031). Additionally, The Asia Pacific region would showcase a CAGR of 5.8% during (2024 - 2031).

List of Key Companies Profiled

• Merck Millipore (Merck KGaA)
• Novozymes A/S (Novo Holdings A/S)
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Takara Bio Inc. (Takara Holdings Inc.)
• Sartorius AG
• PromoCell GmbH
• Geno Technology, Inc.
• Bio-Rad Laboratories, Inc.

Trypsin Market Report Segmentation

By Source

• Bovine
• Porcine
• Others

By Application

• Biotechnology & Pharmaceutical Industry
• Food Industry
• Cosmetics & Personal Care
• Waste Treatment
• Others

By End-use

• Industrial use
• Research
• Diagnostics

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports:

North America Trypsin Market Size & Growth Analysis - 2031

• July-2024
• 101 Pages

LAMEA Trypsin Market Size, Share & Top Key Players 2031

• July-2024
• 111 Pages

Europe Trypsin Market Size, Share & Growth Analysis - 2031

• July-2024
• 111 Pages

Asia Pacific Trypsin Market Size | Forecast Report to 2031

• July-2024
• 111 Pages